Issue 38, 2021

PEGylated AIEgen molecular probe for hypoxia-mediated tumor imaging and photodynamic therapy

Abstract

We report a novel PEGylated aggregation-induced emission luminogen (AIEgen) molecular probe for hypoxia-mediated tumor imaging and photodynamic therapy by linking a PEG chain to the AIE-active photosensitizer via a hypoxia-sensitive azo group.

Graphical abstract: PEGylated AIEgen molecular probe for hypoxia-mediated tumor imaging and photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
20 Feb 2021
Accepted
29 Mar 2021
First published
29 Mar 2021

Chem. Commun., 2021,57, 4710-4713

PEGylated AIEgen molecular probe for hypoxia-mediated tumor imaging and photodynamic therapy

J. Li, W. Liu, Z. Li, Y. Hu, J. Yang and J. Li, Chem. Commun., 2021, 57, 4710 DOI: 10.1039/D1CC00967B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements